Biotech & Life Sciences innovation | Strategic and economic resilience of the Netherlands

International chambers of commerce in the Netherlands alongside with IvCB and Hollandbio organise a lunch-conference on the role of Biotech & Life Sciences innovation in strengthening the strategic and economic resilience of the Netherlands.
 

The geopolitical landscape has been in significant transition over the past couple of years. Where the COVID-19 crisis made it clear that the Netherlands is dependent on international supply chains during a time of a global crisis, current trends have implications with regards to our dependency on supply chains worldwide for the longer term.
 

Why reinvent the wheel when European countries already offer successful examples of how to stimulate innovation? What can we learn from European allies - and how do we translate it into concrete action in the Netherlands? Join us as we explore European best practices and their implications for strengthening Biotech & Life Science innovation and future earning capacity in the Netherlands.
 

During the event, policymakers, knowledge institutions and industry representatives with discuss:

• Strengthening strategic autonomy in the Biotech & Life Sciences sector;
• Accelerating innovation through improved collaboration between
government, science and industry;
• How investment in Biotech & Life Sciences helps ensure access to medicines and prevention, supporting long-term prosperity.
 

The event will bring together Members of Parliament, senior policymakers, representatives of leading life sciences companies, academic institutions and healthcare innovation leaders. Together, these stakeholders reflect the full spectrum of public and private actors shaping the future of Biotech & Life Sciences innovation.

locatie